United States · Funded startup

Who invested in INmuneBIO

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$19Mraised across 1 round since 2025, from 1 source

Latest round
Round, $19MJun 2025
Investors
1
See who backed them

The rounds

  1. Jun 2025
    Round$19M

    Source recorded

Founders and team

From INmuneBIO's own website: 6 on the team.

  • Christopher J. BarnumVice President of Neuroscience
  • David J. MossCEO
  • J. Kelly GanjeiChairman of the Board
  • Marcia AllenDirector
  • Scott JudaDirector
  • Timothy SchroederDirector

Everyone who backed them

SVB CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about INmuneBIO

Who invested in INmuneBIO?

INmuneBIO's investors include SVB Capital.

How much has INmuneBIO raised?

INmuneBIO has raised $19M across 1 round since 2025.

When did INmuneBIO last raise?

INmuneBIO's most recent round was an Undisclosed round of $19M in Jun 2025.

What was INmuneBIO's biggest round?

Its most recent round, $19M in Jun 2025, is also its largest on record.

Who backed INmuneBIO first?

INmuneBIO's first round on record, in Jun 2025, was backed by SVB Capital.

What stage is INmuneBIO at?

INmuneBIO's latest named round is an Undisclosed round, in Jun 2025.

Where is INmuneBIO based?

INmuneBIO is based in the United States.

Companies like INmuneBIO

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.